The incidence and vast spread of the coronavirus disease 2019 has been quite rapid across the globe. There is no medicine approved solely by the FDA for the management of COVID-19 infection. Only symptomatic management is carried out in patients with the available medicines in the market. This review provides an overview of the drugs which are being used primarily for the management of the infection across the globe. The number of drugs being used is comparatively less, hence to provide a view on the mechanism and pharmacology, this review has been carried out. Data on drugs like remdesivir, dexamethasone and tocilizumab have been included in this review, along with supportive care from Siddha to help the medical fraternity to decide on the treatment regimen for COVID-19. Data on the current use of drugs in hospitals were provided by a medical practitioner and are included in this review.

Keywords: COVID-19; Management; Remdesivir; Dexamethasone; Tocilizumab.